Volume 55, Issue 6, Pages (June 1999)

Slides:



Advertisements
Similar presentations
The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy Mouhannad Al-Douahji, James Brugarolas,
Advertisements

Volume 72, Issue 7, Pages (October 2007)
The Role of Neutrophils in the Induction of Glomerulonephritis by Anti-Myeloperoxidase Antibodies  Hong Xiao, Peter Heeringa, Zhi Liu, Dennis Huugen,
Osteopontin expression in human crescentic glomerulonephritis
Renal manifestations in Fabry disease and therapeutic options
Paraneoplastic glomerulopathies: New insights into an old entity
Podocyte involvement in human immune crescentic glomerulonephritis
Regulation of mesangial cell proliferation
Volume 63, Issue 4, Pages (April 2003)
Volume 63, Issue 6, Pages (June 2003)
Volume 63, Issue 1, Pages (January 2003)
Mechanical stress reduces podocyte proliferation in vitro
Volume 76, Issue 12, Pages (December 2009)
Volume 57, Issue 2, Pages (October 2000)
Volume 72, Issue 4, Pages (August 2007)
Volume 63, Issue 1, Pages (January 2003)
Volume 58, Issue 1, Pages (July 2000)
Volume 60, Issue 6, Pages (December 2001)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 54, Issue 6, Pages (January 1998)
Infantile nephropathic cystinosis
Volume 62, Issue 6, Pages (December 2002)
Volume 84, Issue 5, Pages (November 2013)
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Volume 60, Issue 3, Pages (September 2001)
Patricia L. St. John, Dale R. Abrahamson  Kidney International 
Volume 55, Issue 6, Pages (June 1999)
AJKD Atlas of Renal Pathology: Collapsing Glomerulopathy
Volume 60, Issue 3, Pages (September 2001)
Volume 59, Issue 4, Pages (April 2001)
Volume 79, Issue 6, Pages (March 2011)
Volume 55, Issue 4, Pages (April 1999)
Volume 56, Issue 3, Pages (September 1999)
Volume 81, Issue 9, Pages (May 2012)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 54, Issue 5, Pages (November 1998)
Volume 62, Issue 1, Pages (July 2002)
Volume 88, Issue 5, Pages (November 2015)
Volume 70, Issue 8, Pages (October 2006)
Volume 60, Issue 1, Pages (July 2001)
Volume 64, Issue 4, Pages (October 2003)
Volume 83, Issue 6, Pages (June 2013)
Cell cycle regulatory proteins in glomerular disease
Volume 56, Issue 5, Pages (November 1999)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Volume 67, Issue 4, Pages (April 2005)
Volume 77, Issue 8, Pages (April 2010)
Volume 61, Issue 6, Pages (June 2002)
Volume 55, Issue 3, Pages (March 1999)
Volume 72, Issue 3, Pages (August 2007)
Lithium toxicity: A double-edged sword
Volume 58, Issue 6, Pages (December 2000)
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 63, Issue 1, Pages (January 2003)
Volume 66, Issue 5, Pages (November 2004)
Volume 72, Issue 7, Pages (October 2007)
Volume 56, Issue 2, Pages (August 1999)
Volume 67, Issue 3, Pages (March 2005)
Red cell traverse through thin glomerular basement membranes
Volume 60, Issue 5, Pages (November 2001)
Volume 57, Issue 5, Pages (May 2000)
Volume 70, Issue 2, Pages (July 2006)
Effects of cyclosporine in osteopontin null mice1
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 73, Issue 5, Pages (March 2008)
Volume 58, Issue 1, Pages (July 2000)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 68, Issue 1, Pages (July 2005)
Volume 53, Issue 4, Pages (April 1998)
Presentation transcript:

Volume 55, Issue 6, Pages 2349-2361 (June 1999) The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis  Yoon-Goo Kim, Charles E. Alpers, James Brugarolas, Richard J. Johnson, William G. Couser, Stuart J. Shankland  Kidney International  Volume 55, Issue 6, Pages 2349-2361 (June 1999) DOI: 10.1046/j.1523-1755.1999.00504.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Light micrographs of nephritic kidneys at day 5. In both p21+/+ (A) and p21-/- (B) mice, there was vacuolization, detachment, and cyst formation of the visceral glomerular epithelial cells (VECs). PAS-positive material occluded many of the capillary loops, which were associated with capillary collapse, and this was more extensive in the p21-/- mice (B). (C and D) BrdU staining. BrdU staining was increased at day 5 in nephritic p21-/- (D) mice compared with nephritic p21+/+ (C) mice, and the pattern of BrdU staining was predominantly in a VEC distribution. (E) PAS stain of nephritic p21-/- at day 14. There was an occlusion of capillaries and a collapse of the glomerular tuft. Layers of cells filled Bowman's space, and these were in a typical VEC distribution. (F) Ezrin stain. Layers of cells in p21-/- mice at day 14 stained positive for Ezrin, a marker of glomerular epithelial cells. Kidney International 1999 55, 2349-2361DOI: (10.1046/j.1523-1755.1999.00504.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Quantitation of glomerular cell proliferation. Glomerular cell proliferation was measured by the percentage of glomeruli with cell multilayers, which was classified as mild (<3 layers; □) or severe (≥3 layers; ▪). There was no significant difference in the number of multilayered cells at day 5 of glomerulonephritis between p21+/+ and p21-/- mice. At day 14, glomerular cell proliferation increased in nephritic p21-/- mice compared with controls, where the majority of cell multilayers were severe. Kidney International 1999 55, 2349-2361DOI: (10.1046/j.1523-1755.1999.00504.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Electron micrograph of part of a glomerulus from day 14 p21-/- mouse. A capillary loop (C, lower right) is occluded by thrombus and contains part of a leukocyte with numerous cytoplasmic granules. The adjacent urinary space contains clusters of cells showing few cytoplasmic granules prominent rough endoplasmic reticulum and numerous mitochondria. Discrete intercellular junctions between these cells cannot be identified. Kidney International 1999 55, 2349-2361DOI: (10.1046/j.1523-1755.1999.00504.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Quantitation of DNA synthesis. DNA synthesis was measured by immunostaining for proliferating cell nuclear antigen (PCNA; A) and bromodeoxyuridine (BrdU; B). PCNA and BrdU staining was not detected in normal control p21+/+ (○) and p21-/- (□) mice. DNA synthesis increased significantly in nephritic p21-/- mice at day 5 and 14 compared with p21+/+ mice. Kidney International 1999 55, 2349-2361DOI: (10.1046/j.1523-1755.1999.00504.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 5 Indirect immunoperoxidase immunostaining for Wilms’ tumor-1 gene (WT-1) in p21-/- mice. (A) Glomerular cells stain positive for WT-1 in normal p21-/- mice, and this is in a visceral glomerular epithelial cell distribution (arrows). (B) WT-1 staining was not detected in glomerular cell multilayers in p21-/- mice with glomerulonephritis at day 14. Kidney International 1999 55, 2349-2361DOI: (10.1046/j.1523-1755.1999.00504.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 6 Silver staining. There was an increase in silver staining at day 14 in nephritic p21-/- mice (B) compared with p21+/+ mice (A). (C and D) TUNEL staining. TUNEL staining, a marker of apoptosis, was increased at day 14 in nephritic p21-/- mice (D) compared with p21+/+ mice (C). Kidney International 1999 55, 2349-2361DOI: (10.1046/j.1523-1755.1999.00504.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 7 Quantitation of TUNEL staining. There was a statistically significant increase in TUNEL staining in p21-/- mice (□) at day 14 compared with controls (p21+/+; ○). Kidney International 1999 55, 2349-2361DOI: (10.1046/j.1523-1755.1999.00504.x) Copyright © 1999 International Society of Nephrology Terms and Conditions